Candidate gene studies of single polymorphisms in affective disorders and psychosis have produced many intriguing results, but will they ever be definitive? We predict that in the future there will be a convergence of linkage and association analysis to genome-wide linkage disequilibrium studies using overlapping haplotypes.
Allelic association studies in psychiatric disorders have generally focused on a limited number of candidate genes, principally from the dopamine and serotonin systems. These include the neurotransmitter receptors and transporters, and genes of the relevant biochemical pathways such as tyrosine hydroxylase, the monoamine oxidases and catechol-O-methyl transferase. Almost all of these genes have at some stage provided evidence for allelic association with one or more psychiatric diseases, traits or behaviours. Two reports in this issue of Molecular Psychiatry continue this theme through positive associations between genes of the monoamine system and affective disorders. Serretti et al 1 have examined a tetranucleotide polymorphism in intron 1 of the tyrosine hydroxylase (TH) gene and found allelic association between allele 2 and both bipolar and unipolar disorder, whereas Rosenthal et al 2 report association between the short allele of a VNTR in the serotonin transporter promoter polymorphism (5-HTTLPR) and seasonal affective disorders (SAD).
These and many other interesting positive findings cannot be considered definitive because of the statistical problems of multiple testing. In linkage analysis a lod score of 3 is traditionally regarded as being significant, and this corresponds to a P value of 0.0001. It can be argued that the problem of multiple testing is even more severe for association analysis, where there is little biochemical evidence to help identify which candidate genes are most likely to be involved. Although there is no consensus as to the level of significance or the degree of consistency between studies required, it is clear that none of the current studies can be considered conclusive. Indeed, perhaps if one picked any polymorphism at random and ran a plethora of casecontrol candidate gene studies of psychiatric disorders, a similar pattern of positive and negative associations might emerge. Is it that psychiatric genetics is looking Linkage disequilibrium, population heterogeneity and epistasis
There have been mixed replications of even the most significant candidate gene associations, and the estimated increase in susceptibility incurred in subjects with the disease allele is usually very small, with relative risks as low as 1.2. The majority of these associations may turn out to be false-positives, but some will result from more than just chance alone. The marginal significance and low relative risk of many allelic associations may result from the fact that one is not looking at the susceptibility allele itself, but a nearby allele in linkage disequilibrium. For many reasons, including differences in population history and environmental factors, the extent of allelic association observed may vary between different populations, making replication difficult. If the effect of a given gene is epistatically dependent on the effect of a second gene elsewhere in the genome, then allelic associations looking at just a single gene may lack power and reproducibility. These complications argue for the obvious importance of standard and well-validated diagnostic procedures, and the use of large samples in homogeneous populations.
The correct dimension
Another possible reason for inconsistent findings in candidate gene studies may be simply because clinical diagnoses do not have a sufficiently direct relationship with the trait influenced by the susceptibility gene. Thus, the small effect of the recent association reported between a functional polymorphism in the promoter region of the serotonin transporter (the 5-HTTLPR) and depression might be explained by the finding of association with seasonal affective disorder (SAD) by Rosenthal et al. 2 It may be that the 5-HTTLPR primarily influences the seasonal fluctuation rather than the average level of mood. Thus, any association found between depression and the 5-HTTLPR will depend on the proportion of the affected subjects with seasonal mood fluctuation. Since SAD is influenced by local climate, one would not expect replication of association with affective disorders in all populations.
Use of haplotypes
In addition, the extensive use of haplotypes of many markers within and around each gene may be a more powerful strategy than the current tendency to look only at a single polymorphism. There are several reasons for this. A founder mutation is associated with an entire haplotype of surrounding alleles, and so the ability to examine the entire region of the gene must provide much more information than a single polymorphism. Furthermore, if there are multiple mutations of a single gene, which have similar effect on susceptibility, then the complex pattern of associations may cancel out each other when examined alone but may be revealed if haplotypes are used. As a result of the greater power of using haplotypes, differences in results between ethnically diverse populations may become easier to interpret. The apparent lack of replication with a single polymorphism may be revealed as an association with a different haplotype. This also argues for the continued use of linkage approaches, and in this light it is encouraging to see that this approach is being attempted by Balciuniene et al for depression. 3 The type of marker chosen may also influence the chance of observing associations. Biallelic polymorphisms which consist of single base changes are very stable, with mutation rates as low as 1 in 10 8 per generation. Other types of polymorphisms, such as triplet repeats, VNTRs and microsatellites such as dinucleotide (CA) repeats have higher mutation rates. If a disease susceptibility allele is very old in evolutionary history, the strongest linkage disequilibrium relationships may be preserved for biallelic polymorphisms, whereas for more recent mutations the use of more complex but less stable CA repeat or VNTR markers may be more powerful. Since the evolutionary history of susceptibility alleles for complex psychiatric disorders is unknown, the most powerful method of candidate gene analysis will involve the use of haplotypes which will allow information from biallelic, VNTR and other types of markers to be combined.
More polymorphism detection
Haplotype analysis of candidate genes is not necessarily a straightforward procedure since it requires extensive mutation screening of more than just exons. One current notion is that susceptibility alleles for complex psychiatric disorders will reside in promoter regions of genes (which may extend for tens of kilobases from the coding sequence). There is some empirical evidence for this, for example from screening studies of genes such as the serotonin transporter. However, many promoters will be disappointing: one might expect to see polymorphisms every 1 kb or so, and since promoter function is generally insensitive to sequence changes in all but a few key areas, the vast majority will be non-functional. However the extensive diversity of human behaviour must come from somewhere, and it is likely that some promoters will exhibit surprising variability, perhaps with several functional sites.
Family-based haplotype transmission
Methods which look at allele transmission in families, such as the transmission disequilibrium test, have become popular because they avoid the problem of spurious findings arising from poor case-control matching. However, another advantage is that they allow haplotypes to be generated from multiple biallelic, VNTR and flanking microsatellite polymorphisms. Using a case-control sample, it is only possible to reconstruct haplotypes using homozygotes or probabilistic methods. For a small sample size, the number of haplotypes that can be reconstructed can become too small to be useful. In contrast, the use of large family trio or sib-pair samples has substantial advantages, since haplotypes can be reconstructed using parental information and their transmission examined.
Will the real susceptibility allele please stand up
Eventually one will be at a stage where a variety of genetic markers have been examined in and around a candidate gene, over a broad region of say several hundred kb. Handling this information will be difficult in itself since many hundreds of different haplotypes will be possible: for example, for three markers with ten evenly distributed alleles, one thousand possible haplotypes will theoretically exist. Although many of these will be absent, the large number of possibilities means that better methods of analysing haplotype data are required. Such methods will not only be required to detect association, but also to help identify which of the many gene variants are the real culprits in disease susceptibility. Even if a precise identification is not possible, haplotype analysis may nevertheless indicate the best place to look. Genetic analysis alone may not be sufficient to provide a definitive answer, and both a greater effort at functional analysis of gene variants and a return to biochemical genetics to explore the interaction of functional gene variants within and between biochemical pathways may be necessary.
Systematic analysis and the need for LD maps in humans
This type of approach will require much more information on linkage disequilibrium in normal human populations, as well as those with diseases, and the natural outcome of this is the generation of human linkage disequilibrium maps, in the same way that linkage, transcript and physical maps have gone before. Using this information, the next logical step is to move from candidate gene regions to genome-wide system-atic analysis using overlapping markers, or a transcriptbased approach by using a 'cassette' of polymorphisms for each gene. Although the amount of genotyping required for this approach will be vast, and effort-saving strategies such as DNA pooling may not be appropriate, it will provide a sensitive method which will extract maximum linkage and linkage disequilibrium information from the genome. This will not only allow the genome-wide assessment of the role of any candidate gene, but the use of haplotypes to search for evidence of epigenetic interaction between genes.
